Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004411921 | SCV004896628 | uncertain significance | Inborn genetic diseases | 2024-02-28 | criteria provided, single submitter | clinical testing | The c.989C>T (p.S330L) alteration is located in exon 8 (coding exon 8) of the KMT2D gene. This alteration results from a C to T substitution at nucleotide position 989, causing the serine (S) at amino acid position 330 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |